Nasal Drug Delivery Systems Market - Global Forecast to 2026

Posted by priya saraf on August 23rd, 2019

Nasal cavity is becoming one of the most potential and promising route of drug delivery, owing to its advantages such as bypassing the hepatic first-pass metabolism, and most importantly patient convenience. The report provides in depth understanding of developing intranasal formulation to achieve better therapeutic objective, in turn drive the market share.

However, the report also focuses on the practical and technical factors which remains the hindrance for the global nasal drug delivery system market growth over the forecast period. Furthermore, report tracks and forecast the market growth of each segment for the period of 2016-2026.

Request A Sample Copy: http://bit.ly/321QbG3

Market Dynamics

The major factors driving growth of the nasal drug delivery systems market includes, increasing product launches coupled with technologically advanced drug delivery systems and increasing incidence of nasal cavity associated diseases. For instance, in June 2018, Insys Therapeutics, Inc., a specialty pharmaceutical company, conducted clinical trial for epinephrine nasal spray, an alternative for intramuscular injection for the indication of anaphylaxis.

Furthermore, companies have large number of pipeline drugs, which are to be delivered intranasally such as Acerus Pharmaceuticals Corporation is investigating TEFINA, a testosterone nasal gel, for addressing the unmet treatment demand for female sexual dysfunction. However, intranasal route of drug delivery is not suitable for all drug types, which is expected to be a major restrain for growth of the nasal drug delivery systems market.

Increasing awareness about advantages of nasal drug delivery is driving the nasal drug delivery systems market growth

Major advantages of nasal drug delivery is that, the drug circumvents hepatic first-pass metabolism, leading to high bioavailability as compared to drug administered orally. On the other hand, parenteral route of administration is also inconvenient for long term therapeutic treatment.

Nasal cavity being highly vascular enhances the drug absorption resulting in rapid onset of action. Moreover, ease of administration coupled with non-invasive method is driving adoption of nasal drug delivery systems, in turn propelling nasal drug delivery systems market growth.

However, limitations associated with nasal drug delivery system such as histological toxicity or lesser area of absorption as compared to orally administered drug hinders the nasal drug delivery systems market growth.

Furthermore, increasing product launches with nasal drug delivery is also fueling the nasal drug delivery systems market growth. For instance, in 2017, Optinose, an ENT / Allergy specialty pharmaceutical company, received New Drug Application approval for its Xhance, fluticasone propionate, for the indication of nasal polyps in adults. Xhance is a specially designed combination of novel Optinose Exhalation Delivery System and an aqueous suspension of microfine drug delivery for topical intranasal administration via a metered atomizing spray pump. Moreover, the product can be opted for powder and liquid formulation and also addresses the limitation of traditional nasal spray by using its bi-directional delivery.

Nasal drug delivery systems market regional outlook - Asia Pacific is expected to be a rapidly growing market over the forecast period

The regional nasal drug delivery systems market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa by Coherent Market Insights. North America nasal drug delivery systems market is estimated to hold dominant position in 2017. The factors attributed to growth of the North America in nasal drug delivery systems market is increasing research and development by local manufacturers to develop new drug device or delivery system combination.

For instance, Impel NeuroPharma, Inc., a Seattle-based clinical stage biotechnology company, is engaged in applying its Precision Olfactory Delivery (POD) nasal drug delivery platform for drugs such as levodopa powder, insulin liquid, and olanzapine powder for the treatment of Parkinson’s disease, Alzheimer’s disease and agitation in schizophrenia and bipolar disorder, respectively.

The major players operating in nasal drug delivery systems market are Merck & Co., GlaxoSmithKline plc, AstraZeneca plc, Johnson & Johnson, Pfizer Inc., Baxter International, Inc., Valeant Pharmaceuticals International, Inc., Becton, Dickinson and Company, and Novartis AG.

Click To Read More On: Nasal Drug Delivery Systems Market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr.Shah

coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel: +1-206-701-6702

Email:sales@coherentmarketinsights.com

Like it? Share it!


priya saraf

About the Author

priya saraf
Joined: May 23rd, 2019
Articles Posted: 166

More by this author